|
Volumn 92, Issue 3, 2000, Pages 179-181
|
Will there be resistance to the RECIST (response evaluation criteria in solid tumors)?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CANCER INHIBITION;
CLINICAL TRIAL;
COST BENEFIT ANALYSIS;
EDITORIAL;
HUMAN;
INTERNATIONAL COOPERATION;
LEUKEMIA CELL;
META ANALYSIS;
NOMENCLATURE;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
SOLID TUMOR;
|
EID: 0034594626
PISSN: 00278874
EISSN: None
Source Type: Journal
DOI: 10.1093/jnci/92.3.179 Document Type: Editorial |
Times cited : (129)
|
References (8)
|